Polypharmacotherapy in Psychiatry: Global Insights from a Rapid Online Survey of Psychiatrists
In recent years, an increase in the problem of polypharmacotherapy in psychiatric patients has been observed, including the widespread problem of groups of people taking new psychoactive substances. One reason for this problem may be the poor knowledge of pharmacological interactions in psychiatry....
Main Authors: | Michal Ordak, Daria Tkacz, Aniela Golub, Tadeusz Nasierowski, Magdalena Bujalska-Zadrozny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/8/2129 |
Similar Items
-
Polypharmacotherapy and drug-drug interactions in patients hospitalized in an Internal Medicine department: magnitude of the problem and clinical implications
by: Luigi Lusiani, et al.
Published: (2013-04-01) -
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances
by: Aniela Golub, et al.
Published: (2023-05-01) -
Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
by: Annita Kolnagou, et al.
Published: (2022-07-01) -
Increasing the Effectiveness of Pharmacotherapy in Psychiatry by Using a Pharmacological Interaction Database
by: Michal Ordak, et al.
Published: (2021-05-01) -
Deprescribing psychotropic drugs in a geriatric psychiatry outpatient clinic
by: Natascha Melo Linkievicz, et al.
Published: (2024-04-01)